Dr. John F. Deeken
Claim this profileInova Schar Cancer Institute
Studies Cancer
Studies Squamous Cell Carcinoma
6 reported clinical trials
12 drugs studied
Area of expertise
1Cancer
p16 positive
Stage IV
p16 negative
2Squamous Cell Carcinoma
p16 positive
p16 negative
Stage IV
Affiliated Hospitals
Clinical Trials John F. Deeken is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
More about John F. Deeken
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments John F. Deeken has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Image Guided Radiation Therapy
- Fluorouracil
- Gemcitabine Hydrochloride
- Paclitaxel
Breakdown of trials John F. Deeken has run
Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John F. Deeken specialize in?
John F. Deeken focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved p16 positive patients, or patients who are Stage IV.
Is John F. Deeken currently recruiting for clinical trials?
Yes, John F. Deeken is currently recruiting for 4 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that John F. Deeken has studied deeply?
Yes, John F. Deeken has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Image Guided Radiation Therapy.
What is the best way to schedule an appointment with John F. Deeken?
Apply for one of the trials that John F. Deeken is conducting.
What is the office address of John F. Deeken?
The office of John F. Deeken is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.